The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
Open accessAbstract
Adiponectin has recently been shown to be a promising candidate for the treatment of obesity-associated metabolic syndromes. Replenishment of recombinant adiponectin in mice can decrease hyperglycemia, reverse insulin resistance, and cause sustained weight loss without affecting food intake. Here we report its potential roles in alcoholic and nonalcoholic fatty liver diseases in mice. Circulating concentrations of adiponectin decreased significantly following chronic consumption of high-fat ethanol-containing food. Delivery of recombinant adiponectin into these mice dramatically alleviated hepatomegaly and steatosis (fatty liver) and also significantly attenuated inflammation and the elevated levels of serum alanine aminotransferase. These therapeutic effects resulted partly from the ability of adiponectin to increase carnitine palmitoyltransferase I activity and enhance hepatic fatty acid oxidation, while it decreased the activities of two key enzymes involved in fatty acid synthesis, including acetyl-CoA carboxylase and fatty acid synthase. Furthermore, adiponectin treatment could suppress the hepatic production of TNF-α and plasma concentrations of this proinflammatory cytokine. Adiponectin was also effective in ameliorating hepatomegaly, steatosis, and alanine aminotransferase abnormality associated with nonalcoholic obese, ob/ob mice. These results demonstrate a novel mechanism of adiponectin action and suggest a potential clinical application of adiponectin and its agonists in the treatment of liver diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adiponectin administration decreases IHTG (35), increases hepatic insulin sensitivity (36), and reverses obesity-related skeletal muscle insulin resistance (37).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [35]
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,261
Novel Modulator for Endothelial Adhesion Molecules
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,158
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,114
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.2005 · Cited by 2,007
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 998
Metabolic effect of short term administration of Hoodia gordonii, an herbal appetite suppressant
Jain, S., & Singh, S. N. (2013) · South African Journal of Botany · doi:10.1016/j.sajb.2013.02.002 · Cited by 21
Pepping, J. K., Otvos, L. J., Surmacz, E., Gupta, S., Keller, J. N., & Bruce‐Keller, A. J. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9529-1 · Cited by 21
Pummoung, S., Werawatganon, D., Chayanupatkul, M., Klaikeaw, N., & Siriviriyakul, P. (2020) · Antioxidants · doi:10.3390/antiox10010024 · Cited by 21
Mallat, A., & Lotersztajn, S. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74604-4 · Cited by 21
An adipocentric view of liver fibrosis and cirrhosis.
Chuang, J., Wang, P., & Tai, M.-H. (2004) · PubMed · Cited by 21
Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease
Cortez‐Pinto, H., & Machado, M. V. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.2.217 · Cited by 21
Jo, M. G., Kim, M. W., Jo, M. H., Abid, N. B., & Kim, M. O. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0383-3 · Cited by 21
Leptin in the Field of Hepatic Fibrosis: A Pivotal or an Incidental Player?
Bethanis, S., & Theocharis, S. E. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9126-0 · Cited by 21
Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease
Angın, Y., Arslan, N., & Kuralay, F. (2014) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2014.1361 · Cited by 20
Arumugam, M. K., Chava, S. P., Rasineni, K., Paal, M. C., Donohue, T. M., Osna, N. A., & Kharbanda, K. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-94180-x · Cited by 19
Cha, A., Choi, Y., Jin, Y., Sung, M., Koo, Y.-C., Lee, K., & Park, T. (2011) · BioMed Research International · doi:10.1155/2012/141395 · Cited by 20
Identification of amino-terminal region of adiponectin as a physiologically functional domain
Ujiie, H., Oritani, K., Kato, H., Yokota, T., Takahashi, I., Maeda, T., Masaie, H., Ichii, M., Kamada, Y., Tamura, S., et al. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20779 · Cited by 20
Potter, J. J., & Mezey, E. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00529.x · Cited by 19
Role of adiponectin in adipose tissue wound healing
Jin, C., Xiao, L., Ge, Z.-H., Zhan, X., & Zhou, H. (2015) · Genetics and Molecular Research · doi:10.4238/2015.august.3.11 · Cited by 20
Lin, Y., Pan, Y., Jiang, T., Chen, Y., Shang, T., Xu, M., Feng, H.-B., Ma, Y., Tan, Y., Wang, H., et al. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01124-y · Cited by 21
Hypoadiponectinemia in Obesity: Association with Insulin Resistance
Prakash, J., Mittal, B., Awasthi, S., Agarwal, C. G., & Srivastava, N. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0246-3 · Cited by 20
Protective Effects of Korean Red Ginseng against Alcohol-Induced Fatty Liver in Rats
Lee, H. W., Ok, H. M., & Kwon, O. (2015) · Molecules · doi:10.3390/molecules200611604 · Cited by 19
Kawamoto, R., Tabara, Y., Kohara, K., Miki, T., Ohtsuka, N., Kusunoki, T., & Abe, M. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.4879 · Cited by 19
Sogabe, M., Okahisa, T., Taniguchi, T., Tomonari, T., Tanaka, T., Tanaka, H., Nakasono, M., & Takayama, T. (2014) · Liver International · doi:10.1111/liv.12754 · Cited by 19
White, P. A. S., Araújo, J. M. D., Cercato, L. M., de Souza, L. A. J., Barbosa, A. P. O., Quintans‐Júnior, L. J., Machado, U. F., Camargo, E. A., Brito, L. C., & dos Santos, M. R. V. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2015.0034 · Cited by 20
Ma, L., Xie, C., Ran, Y., Liang, X., Huang, L., Pei, H., Chen, J., Liu, J., Sang, Y., Lai, H., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301164y · Cited by 19
Markers in Nonalcoholic Steatohepatitis
Armutçu, F., Akyol, S., Uçar, F., Erdoğan, S., & Akyol, Ö. (2013) · Advances in clinical chemistry · doi:10.1016/b978-0-12-407680-8.00004-x · Cited by 19
The Role of Visceral Adipose Tissue in the Pathogenesis of Non-alcoholic Fatty Liver Disease
Verrijken, A., Francque, S., & Gaal, L. V. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2011.07.02.96 · Cited by 18
Adipokines and the clinical laboratory: what to measure, when and how?
Hill, M. J., Kumar, S., & McTernan, P. G. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.049171 · Cited by 19
Significance of ALT/AST ratio for specifying subjects with metabolic syndrome in its silent stage
Ohgo, H., Yokoyama, H., Hirose, H., Kawabe, H., Saito, I., Tomita, K., & Hibi∥, T. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2008.10.001 · Cited by 19
El-Kader, S., Al-Jiffri, O., & Al-Shreef, F. M. (2014) · African Health Sciences · doi:10.4314/ahs.v14i3.8 · Cited by 20
Nonalcoholic fatty liver disease and metabolic syndrome: a concise review.
Streba, L. A. M., Cârstea, D., Mitruț, P., Vere, C. C., Dragomir, N., & Streba, C. T. (2008) · PubMed · Cited by 19
Maeda, K., Ishihara, K., Miyake, K., Kaji, Y., Kawamitsu, H., Fujii, M., Sugimura, K., & Ohara, T. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.020 · Cited by 19
Therapeutic Targets and Approaches to Manage Inflammation of NAFLD
Geng, W., Liao, W., Cao, X., & Yang, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13020393 · Cited by 20
Nonalcoholic Fatty Liver Disease
Fitzpatrick, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-80068-0_69 · Cited by 19
Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?
Mitsala, A., Tsalikidis, C., Romanidis, Κ., & Pitiakoudis, M. S. (2022) · Current Oncology · doi:10.3390/curroncol29070356 · Cited by 22
Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators
Serhal, R., Hilal, G., Boutros, G., Sidaoui, J., Wardi, L., Ezzeddine, S., & Alaaeddine, N. (2015) · BioMed Research International · doi:10.1155/2015/850246 · Cited by 18
Uraki, S., Tameda, M., Sugimoto, K., Shiraki, K., Takei, Y., Nobori, T., & Ito, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131346 · Cited by 18
Intestinal GATA4 deficiency protects from diet-induced hepatic steatosis
Patankar, J. V., Obrowsky, S., Doddapattar, P., Höefler, G., Battle, M. A., Levak‐Frank, S., & Kratky, D. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.028 · Cited by 18
Matafome, P. N., Rodrigues, T., Pereira, A., Letra, L., Azevedo, H., Paixão, A. D. O., Silvério, M. N. O., ALMEIDA, A. A., Sena, C. M., & Seiça, R. M. F. (2014) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2014.950590 · Cited by 18
Long-term effects of angiotensin-(1–7) on lipid metabolism in the adipose tissue and liver
Moreira, C. C. L., Lourenço, F. C., Mário, É. G., Santos, R. A. S., Botion, L. M., & Chaves, V. E. (2017) · Peptides · doi:10.1016/j.peptides.2017.04.004 · Cited by 18
Yin, M., Wang, Z., Liu, W., & Mong, M. (2017) · Journal of Food Science · doi:10.1111/1750-3841.13930 · Cited by 18
Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice
Choung, S., Joung, K. H., You, B. R., Park, S. K., Kim, H. J., & Ku, B. J. (2018) · PPAR Research · doi:10.1155/2018/4292509 · Cited by 18
Nonalcoholic fatty liver disease: emerging mechanisms and consequences
Turkish, A. R. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3282f44bf4 · Cited by 18
dos Santos, B., Estadella, D., Hachul, A. C. L., Okuda, M. H., Moreno, M. F., Oyama, L. M., Ribeiro, E. B., & do Nascimento, C. M. D. P. O. (2013) · Mediators of Inflammation · doi:10.1155/2013/594958 · Cited by 18
The impact of glutathione transferase kappa deficiency on adiponectin multimerisation in vivo
Theodoratos, A., Blackburn, A. C., Coggan, M., Cappello, J., Larter, C. Z., Matthaei, K. I., & Philip G. Board (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.267 · Cited by 20
Lee, H. J., Lim, Y., & Yang, S. J. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.06.001 · Cited by 18
Adiponectin and Alcoholic Fatty Liver: Is It, After All, About What You Eat? * #
Anania, F. A. (2005) · Hepatology · doi:10.1002/hep.20861 · Cited by 18
Kajikawa, S., Harada, T., Kawashima, A., Imada, K., & Mizuguchi, K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.01.014 · Cited by 18
Morris, A., Sennello, J. A., Fayad, R., Eckel, R. H., Dinarello, C. A., & Fantuzzi, G. (2006) · Metabolism · doi:10.1016/j.metabol.2005.11.008 · Cited by 19
Mucus mediated protection against acute colitis in adiponectin deficient mice
Kaur, K., Saxena, A., Larsen, B., Truman, S. C., Biyani, N., Fletcher, E., Baliga, M. S., Ponemone, V., Hegde, S., Chanda, A., et al. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0079-y · Cited by 16
Huang, Y., Qu, H., Liu, D., Wa, Y., Sang, J., Yin, B., Chen, D., Chen, X., & Gu, R. (2020) · RSC Advances · doi:10.1039/d0ra05694d · Cited by 17
Adiponectin’s roles in lipid and glucose metabolism modulation in fish: Mechanisms and perspectives
Ji, R., Xu, X., Turchini, G. M., Mai, K., & Ai, Q. (2021) · Reviews in Aquaculture · doi:10.1111/raq.12569 · Cited by 17
Ghezelbash, B., Shahrokhi, N., Khaksari, M., Asadikaram, G., Shahrokhi, M., & Shirazpour, S. (2022) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-022-3307-3 · Cited by 17
Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease
Chui, Z. S. W., Xue, Y., & Xu, A. (2024) · Medical Review · doi:10.1515/mr-2024-0007 · Cited by 21
Self-citationAdiponectin and Its Receptors in Chronic Hepatitis B Patients With Steatosis in China
Wu, D., Li, H., Xiang, G., Zhang, L., Li, L., Cao, Y., & Zhang, J. (2013) · Hepatitis Monthly · doi:10.5812/hepatmon.6065 · Cited by 17
Zhang, X., Zhong-zhuan, L., Liu, D., Xu, X. P., Mei, Z., & Shen, W. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05129.x · Cited by 17
Latif, H. A., Assal, H. S., Mahmoud, M., & Rasheed, W. I. (2010) · Clinical and Experimental Medicine · doi:10.1007/s10238-010-0108-3 · Cited by 17
Evolving therapies for non-alcoholic steatohepatitis
Tilg, H., & Moschen, A. R. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.911283 · Cited by 18
Miuma, S. (2009) · Oncology Reports · doi:10.3892/or_00000583 · Cited by 17
Dietary Niacin Supplementation Suppressed Hepatic Lipid Accumulation in Rabbits
Liu, L., Li, C., Fu, C., & Li, F. (2016) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.15.0824 · Cited by 17
Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment
Yang, Y., Zhao, Y., Li, W., Wu, Y., Wang, X., Wang, Y., Liu, T.-M., Ye, T., Xie, Y., Cheng, Z., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112311 · Cited by 17
Self-citationImpact of Nutrition and Obesity on Chronic Liver Disease
Manne, V., & Saab, S. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.008 · Cited by 17
Wang, Y., Jiang, Z., Chen, M., Wu, M., Guo, H., Sun, L., Wang, H., Zhang, S., Wang, T., & Zhang, L. (2014) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(14)60072-8 · Cited by 17
Self-citationQin, C., Wang, B., Sun, C., Jia, J., & Li, W. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.12.013 · Cited by 17
Endocrine Adiponectin‐FGF15/19 Axis in Ethanol-Induced Inflammation and Alcoholic Liver Injury
You, M., Zhou, Z., Daniels, M. J., & Jogasuria, A. P. (2017) · Gene Expression · doi:10.3727/105221617x15093738210295 · Cited by 17
Hidalgo, I., Nájera, N., Meaney, E., Duran, J. P., Valdespino-Vázquez, M. Y., Villarreal, F. J., & Ceballos, G. M. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108296 · Cited by 17
Roles of adipokines in liver injury and fibrosis
Wang, J., Brymora, J., & George, J. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.1.47 · Cited by 17
Advances in alcoholic liver disease
Song, Z., Joshi‐Barve, S., Barve, S., & McClain, C. J. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0029-y · Cited by 17
Stejskal, D., Růžička, V., Fanfrdlová, G., Kolář, V., & Bartek, J. (2005) · Biomedical Papers · doi:10.5507/bp.2005.011 · Cited by 17
Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Xu, G., Ma, S., Dong, L., Méndez‐Sánchez, N., Li, H., & Qi, X. (2023) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2023/5521239 · Cited by 16
Lei, X., Peng, Y., Li, Y., Chen, Q., Shen, Z., Yin, W., Lemiasheuski, V., Xu, S., & He, J. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107165 · Cited by 17
White adipose tissue in metabolic associated fatty liver disease
Zhu, X., Zeng, C., & Yu, B. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102336 · Cited by 18
Higurashi, S., Ogawa, A., Nara, T., Kato, K., & Kadooka, Y. (2016) · Dairy Science and Technology · doi:10.1007/s13594-016-0288-z · Cited by 16
Okazaki, Y., Sekita, A., & Katayama, T. (2018) · Biomedical Reports · doi:10.3892/br.2018.1079 · Cited by 16
Effective Food Ingredients for Fatty Liver: Soy Protein β-Conglycinin and Fish Oil
Yamazaki, T., Li, D., & Ikaga, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124107 · Cited by 16
Li, Y., Chao, X., Wang, S., Williams, J. A. R., Ni, H., & Ding, W. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.09.023 · Cited by 16
Ghrelin regulates adipose tissue metabolism: Role in hepatic steatosis
Rasineni, K., Kubik, J. L., Knight, K. L., Hall, L., Casey, C. A., & Kharbanda, K. K. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109059 · Cited by 16
Inafuku, M., Nagao, K., Nomura, S., Shirouchi, B., Inoue, N., Nagamori, N., Nakayama, H., Toda, T., & Yanagita, T. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511003485 · Cited by 16
Effects of adiponectin transgenic expression in liver of nonalcoholic steatohepatitis model mice
Nakayama, H., Otabe, S., Yuan, X., Ueno, T., Hirota, N., Fukutani, T., Wada, N., Hashinaga, T., & Yamada, K. (2009) · Metabolism · doi:10.1016/j.metabol.2009.03.004 · Cited by 16
Zhang, X., Zhong-zhuan, L., Liu, D., Xu, X. Y., Shen, W., & Mei, Z. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05719.x · Cited by 16
Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology
Akter, S. (2022) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2022.270 · Cited by 20
miR-27b targets MAIP1 to mediate lipid accumulation in cultured human and mouse hepatic cells
Sakai, E., Imaizumi, T., Suzuki, R., Taracena-Gándara, M., Fujimoto, T., Sakurai, F., & Mizuguchi, H. (2023) · Communications Biology · doi:10.1038/s42003-023-05049-w · Cited by 15
Marecki, J. C., Ronis, M. J. J., Shankar, K., & Badger, T. M. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.01.001 · Cited by 15
Takagi, Y., Sugimoto, T., Kobayashi, M., Shirai, M., & Asai, F. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3671892 · Cited by 15
de Oliveira, M., Rodrigues, B. M., Olímpio, R. M. C., Mathias, L. S., Síbio, M. T. D., Moretto, F. C. F., Graceli, J. B., & Nogueira, C. R. (2019) · Lipids · doi:10.1002/lipd.12135 · Cited by 15
Noce, A., Marrone, G., Daniele, F. D., Lauro, M. D., Zaitseva, A. P., Jones, G. W., LORENZO, A. D., & Daniele, N. D. (2020) · Nutrients · doi:10.3390/nu12092519 · Cited by 17
AMP-activated protein kinase and muscle insulin resistance
Edward, W. K. (2009) · Frontiers in bioscience · doi:10.2741/3558 · Cited by 15
The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity
Cusi, K. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_1 · Cited by 15
Kim, J., Kim, Y. S., Lee, H. A., Lim, J. Y., Kim, M. K., Kwon, O., Ko, H.-C., Kim, S.-J., Shin, J.-H., & Kim, Y. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.2916 · Cited by 15
NASH: are genes blowing the hits?
Marra, F. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.005 · Cited by 15
The medical complications of alcohol use: understanding mechanisms to improve management
Chase, V., Neild, R., Sadler, C., & Batey, R. G. (2005) · Drug and Alcohol Review · doi:10.1080/09595230500167510 · Cited by 15
Nonalcoholic Fatty Liver Disease
Puri, P., & Sanyal, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00053-x · Cited by 16
Xue, R., Zhang, S., Deng, C., Dong, L., Liu, T., Wang, J., Wu, H., Gu, J., & Shen, X. (2007) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3350 · Cited by 15
Long, W., ju, Z. H., Zhang, F., Wang, J., & Li, Q. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.07.003 · Cited by 15
Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis
Pοlyzos, S. A., Kountouras, J., & Zavos, C. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00632.x · Cited by 15
Adiponectin and peptide YY in the fasting blue fox (Alopex lagopus)
Mustonen, A., Pyykönen, T., & Nieminen, P. (2005) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpb.2005.01.003 · Cited by 15
Lipid-Lowering Drugs and Circulating Adiponectin
Wanders, D., Plaisance, E. P., & Judd, R. L. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-398313-8.00013-0 · Cited by 15
Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review
Torosian, K., Lal, E., Kavanaugh, A., Loomba, R. S., Ajmera, V. H., & Gumá, M. (2023) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2023.152165 · Cited by 15
Dusilová, T., Kovář, J., Laňková, I., Thieme, L., Hubáčková, M., Šedivý, P., Pajuelo, D., Burian, M., Dezortová, M., Miklánková, D., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206100 · Cited by 15
Ye, X.-F., Qi, J., Wu, Y., Yu, D., Xu, P., Li, S., Zhu, S., Wu, Q., Ren, G., & Li, D. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.09.001 · Cited by 14
Adiponectin as a therapeutic target for obesity‐related metabolic and cardiovascular disorders
Wang, Y., Lam, K. S. L., & Xu, A. (2006) · Drug Development Research · doi:10.1002/ddr.20141 · Cited by 14
Self-citationMo, Q., Zhou, G., Xie, B., Ma, B., Zang, X., Chen, Y., Cheng, L., Zhou, J. H., & Wang, Y. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-2817-9 · Cited by 14
Self-citationThe anti-inflammatory effect of Pien Tze Huang in non-alcoholic fatty liver disease
Lian, B., Cai, L., Zhang, Z., Fen, L., Li, Z., Zhang, X.-K., & Jiang, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113076 · Cited by 14
Pathophysiological Similarities and Synergisms in Alcoholic and Non-Alcoholic Steatohepatitis
Hellerbrand, C. (2010) · Digestive Diseases · doi:10.1159/000324286 · Cited by 14
Metadata
- Authors
- Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S.
- Affiliations
- University of Auckland (NZ)
- University of Hong Kong (HK)
- Corresponding author
- Xu, Aimin
- Venue
- Journal of Clinical Investigation
- Published
- 2003-07-01
- Volume
- 112
- Issue
- 1
- Pages
- 91-100
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC162288
- OpenAlex
- W2120590109
- Cited by
- 1,298
- References
- 68
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 29 · 2023: 34 · 2022: 34 · 2021: 43 · 2020: 38 · 2019: 35 · 2018: 54 · 2017: 50 · 2016: 50 · 2015: 69 · 2014: 75 · 2013: 59 · 2012: 68
- FWCI
- 49.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Auckland Medical Research Foundation
- University of Hong Kong
- Health Research Council of New Zealand
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- adiponectin, alcoholic fatty liver, non-alcoholic fatty liver disease, hepatic steatosis, hepatomegaly, liver inflammation, TNF-α, carnitine palmitoyltransferase 1, hepatic fatty acid oxidation, fatty acid synthesis, acetyl-CoA carboxylase, fatty acid synthase, alanine aminotransferase, ob/ob mice, obesity
- MeSH terms
- Alanine Transaminase, Animals, Fatty Acids, Fatty Liver, Fatty Liver, Alcoholic, Liver, Male, Mice, Inbred C57BL, Obesity, Morbid, Oxidation-Reduction, Proteins, Recombinant Proteins, Tumor Necrosis Factor-alpha, Intercellular Signaling Peptides and Proteins, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review